Colonial Trust Advisors Trims Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)
Colonial Trust Advisors trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 44,880 shares of the healthcare conglomerate’s stock after selling 764 shares during the quarter. UnitedHealth Group makes up about 2.2% of Colonial Trust Advisors’ portfolio, making the stock its 11th biggest position. Colonial Trust Advisors’ holdings in UnitedHealth Group were worth $13,992,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of UNH. JJJ Advisors Inc. raised its holdings in shares of UnitedHealth Group by 1,820.0% in the third quarter. JJJ Advisors Inc. now owns 96 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 91 shares during the period. Exchange Traded Concepts LLC raised its holdings in shares of UnitedHealth Group by 140.0% in the second quarter. Exchange Traded Concepts LLC now owns 132 shares of the healthcare conglomerate’s stock worth $39,000 after buying an additional 77 shares during the period. Old North State Trust LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth $39,000. Your Advocates Ltd. LLP increased its holdings in UnitedHealth Group by 33.3% during the 2nd quarter. Your Advocates Ltd. LLP now owns 400 shares of the healthcare conglomerate’s stock worth $44,000 after purchasing an additional 100 shares during the period. Finally, Clean Yield Group increased its holdings in UnitedHealth Group by 38.5% during the 3rd quarter. Clean Yield Group now owns 144 shares of the healthcare conglomerate’s stock worth $45,000 after purchasing an additional 40 shares during the period. Hedge funds and other institutional investors own 86.39% of the company’s stock.
Several research firms have commented on UNH. Jefferies Financial Group raised their price objective on UnitedHealth Group from $310.00 to $335.00 and gave the stock a “hold” rating in a report on Thursday, October 15th. Mizuho restated a “buy” rating and set a $315.00 price objective on shares of UnitedHealth Group in a report on Wednesday, July 15th. UBS Group raised their price objective on UnitedHealth Group from $319.00 to $330.00 and gave the stock a “neutral” rating in a report on Friday, October 16th. Argus downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, October 19th. Finally, ValuEngine upgraded UnitedHealth Group from a “sell” rating to a “hold” rating in a report on Thursday, October 1st. Five analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $346.68.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.98 by $0.53. The firm had revenue of $65.12 billion during the quarter, compared to analysts’ expectations of $63.97 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the firm earned $3.88 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 16.78 earnings per share for the current year.
In related news, EVP Marianne D. Short sold 12,000 shares of the firm’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $321.34, for a total value of $3,856,080.00. Following the completion of the transaction, the executive vice president now owns 140,885 shares in the company, valued at approximately $45,271,985.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $320.59, for a total value of $4,808,850.00. Following the completion of the transaction, the director now owns 159,215 shares of the company’s stock, valued at approximately $51,042,736.85. The disclosure for this sale can be found here. Insiders sold a total of 37,336 shares of company stock valued at $11,893,276 in the last three months. Insiders own 0.80% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Read More: Understanding the two types of arbitrage
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.